Director/PDMR Shareholding

RNS Number : 6290B

GlaxoSmithKline PLC

04 April 2013

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 28 March 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.25 per Ordinary Share, and notional ADSs at a price of $46.43 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2013 to 31 March 2013:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,786.885
Professor Sir Roy Anderson	594.262
Dr Stephanie Burns		497.227
Stacey Cartwright	471.311
Sir Crispin Davis	1,885.246
Lynn  Elsenhans		1,128.489
Judy Lewent		486.418
Sir Deryck Maughan		994.454
Dr Daniel Podolsky		1,134.975
Tom de Swaan	553.279
Jing Ulrich		313.469
Sir Robert Wilson	594.262

The Company and the Non-Executive Directors were informed of these allocations on 3 April 2013.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

4 April 2013

 

END

 

 

RDSQZLFBXZFBBBV